Gene of the month: GATA3

Immunohistochemical based molecular subtypes of muscle-invasive bladder cancer: association with HER2 and EGFR alterations, neoadjuvant chemotherapy response and survival

(2023) Duaa S. Helal et al.   Diagnostic Pathology

GATA3 immunohistochemistry as a diagnostic adjunct for differentiated vulvar intraepithelial neoplasia: utility and limitations

(2023) Somaye Y. Zare et al.   HUMAN PATHOLOGY

GATA3 positivity is associated with poor prognosis in patients with oesophageal squamous cell carcinoma

(2022) Zhikai Chi et al.   JOURNAL OF CLINICAL PATHOLOGY

Sources, resolution and physiological relevance of R-loops and RNA–DNA hybrids

(2022) Eva Petermann et al.   NATURE REVIEWS MOLECULAR CELL BIOLOGY

GATA3 Predicts the Tumor Microenvironment Phenotypes and Molecular Subtypes for Bladder Carcinoma

(2022) Qixin Zhang et al.   Frontiers in Surgery

GATA3 positively regulates PAR1 to facilitate in vitro disease progression and decrease cisplatin sensitivity in neuroblastoma via inhibiting the hippo pathway

(2022) Jing Wang et al.   ANTI-CANCER DRUGS

Immunohistochemical Expression of Renin & GATA3 Help Distinguish Juxtaglomerular Cell Tumors from Renal Glomus Tumors

(2022) Sounak Gupta et al.   HUMAN PATHOLOGY

CK5/6 and GATA3 Defined Phenotypes of Muscle-Invasive Bladder Cancer: Impact in Adjuvant Chemotherapy and Molecular Subtyping of Negative Cases

(2022) Florestan J. Koll et al.   Frontiers in Medicine

Low‐grade oncocytic tumour of the kidney is characterised by genetic alterations of TSC1 , TSC2 , MTOR or PIK3CA and consistent GATA3 positivity

(2022) Sean R Williamson et al.   HISTOPATHOLOGY

GATA3 expression loss is linked to stage progression but is unrelated to prognosis in muscle-invasive urothelial carcinoma of the bladder

(2022) Henning Plage et al.   HUMAN PATHOLOGY

Role of GATA3 in tumor diagnosis: A review

(2021) Mahdis Khazaeli Najafabadi et al.   PATHOLOGY RESEARCH AND PRACTICE

Impact of immunohistochemistry-based subtyping of GATA3, CK20, CK5/6, and CK14 expression on survival after radical cystectomy for muscle-invasive bladder cancer

(2021) Tanan Bejrananda et al.   Scientific Reports

Interaction of the pioneer transcription factor GATA3 with nucleosomes

(2020) Hiroki Tanaka et al.   Nature Communications

Collision Tumor of Urothelial Cell Carcinoma and Clear Cell Renal Cell Carcinoma

(2019) Jon Griffin et al.   APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY

Papillary Renal Neoplasm With Reverse Polarity

(2019) Khaleel I. Al-Obaidy et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Incidence and Significance of GATA3 Positivity in Pancreatic Ductal Adenocarcinoma and Cholangiocarcinoma

(2019) Diana Agostini-Vulaj et al.   APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY

GATA3 zinc finger 2 mutations reprogram the breast cancer transcriptional network

(2018) Motoki Takaku et al.   Nature Communications

Divergent lncRNA GATA3-AS1 Regulates GATA3 Transcription in T-Helper 2 Cells

(2018) Hunter R. Gibbons et al.   Frontiers in Immunology

Impact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant Chemotherapy

(2017) Roland Seiler et al.   EUROPEAN UROLOGY

GATA3 expression in benign prostate glands with radiation atypia: a diagnostic pitfall

(2017) Wei Tian et al.   HISTOPATHOLOGY

Prognostic impact of GATA binding protein-3 expression in primary lung adenocarcinoma

(2017) Toshihiro Hashiguchi et al.   HUMAN PATHOLOGY

GATA3 as a valuable marker to distinguish clear cell papillary renal cell carcinomas from morphologic mimics

(2017) Jose G. Mantilla et al.   HUMAN PATHOLOGY

The utility of CDX2, GATA3, and DOG1 in the diagnosis of testicular neoplasms: an immunohistochemical study of 109 cases

(2016) Hany Osman et al.   HUMAN PATHOLOGY

Akt1-mediated Gata3 phosphorylation controls the repression of IFNγ in memory-type Th2 cells

(2016) Hiroyuki Hosokawa et al.   Nature Communications

Erratum: The somatic mutation profiles of 2,433 breast cancers refine their genomic and transcriptomic landscapes

(2016) Bernard Pereira et al.   Nature Communications

Meta-Analysis of the Luminal and Basal Subtypes of Bladder Cancer and the Identification of Signature Immunohistochemical Markers for Clinical Use

(2016) Vipulkumar Dadhania et al.   EBioMedicine

FOXA1, GATA3 and PPARɣ Cooperate to Drive Luminal Subtype in Bladder Cancer: A Molecular Analysis of Established Human Cell Lines

(2016) Joshua I. Warrick et al.   Scientific Reports

GATA3 expression in gestational trophoblastic tissues and tumours

(2015) Jelena Mirkovic et al.   HISTOPATHOLOGY

Methylation of Gata3 Protein at Arg-261 Regulates Transactivation of theIl5Gene in T Helper 2 Cells

(2015) Hiroyuki Hosokawa et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Non-eosinophilic Airway Hyper-reactivity in Mice, Induced by IFN-γProducing CD4+and CD8+Lung T cells, is Responsive to Steroid Treatment

(2014) J. Stein et al.   SCANDINAVIAN JOURNAL OF IMMUNOLOGY

Value of GATA3 Immunostaining in the Diagnosis of Parathyroid Tumors

(2014) Nelson G. Ordóñez   APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY

GATA3

(2013) Markku Miettinen et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

GATA3 expression in breast carcinoma: utility in triple-negative, sarcomatoid, and metastatic carcinomas

(2013) Ashley Cimino-Mathews et al.   HUMAN PATHOLOGY

GATA3 expression in paragangliomas: a pitfall potentially leading to misdiagnosis of urothelial carcinoma

(2013) Jeffrey S So et al.   MODERN PATHOLOGY

GATA3 acts upstream of FOXA1 in mediating ESR1 binding by shaping enhancer accessibility

(2012) V. Theodorou et al.   GENOME RESEARCH

Comprehensive molecular portraits of human breast tumours

(2012) Daniel C. Koboldt et al.   NATURE

DNA Binding by GATA Transcription Factor Suggests Mechanisms of DNA Looping and Long-Range Gene Regulation

(2012) Yongheng Chen et al.   Cell Reports